epirubicin has been researched along with Bare Lymphocyte Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fichtner, I; Goan, SR; Herrmann, F; Just, U; Karawajew, L; Krause, KP; Schultze, W; von Harsdorf, S; von Schilling, C | 1 |
1 other study(ies) available for epirubicin and Bare Lymphocyte Syndrome
| Article | Year |
|---|---|
The severe combined immunodeficient-human peripheral blood stem cell (SCID-huPBSC) mouse: a xenotransplant model for huPBSC-initiated hematopoiesis.
Topics: Adult; Animals; Antibody Formation; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Breast Neoplasms; Cell Line; Chimera; Cisplatin; Cyclophosphamide; Epirubicin; Etoposide; Female; Fibroblasts; Fluorouracil; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Ifosfamide; Interleukin-3; Lymphoid Tissue; Male; Mice; Mice, SCID; Middle Aged; Ovarian Neoplasms; Rats; Severe Combined Immunodeficiency; Testicular Neoplasms; Transplantation, Heterologous | 1995 |